Vascular complications significantly increase morbidity during acute pancreatic inflammation. While splanchnic venous thrombosis occurs frequently in clinical practice, arterial thrombosis acute pancreatitis represents an exceptionally rare and life-threatening manifestation. Clinicians typically associate severe vascular compromise with necrotizing disease. However, evidence shows that widespread macrovascular thrombosis can also complicate interstitial edematous forms. Recognizing this atypical vascular pathology promptly is essential to prevent extensive tissue ischemia, visceral infarction, and avoidable patient mortality.

Clinical Presentation of Arterial Thrombosis Acute Pancreatitis

A recent clinical report describes a 61-year-old male with acute interstitial edematous pancreatitis superimposed on chronic disease. Initially, the patient received standard supportive therapy, but he continued to suffer from persistent dyspeptic symptoms. Consequently, treating physicians ordered a contrast-enhanced computed tomography scan four weeks after initial presentation. The cross-sectional imaging unexpectedly demonstrated pancreatic pseudocysts alongside extensive arterial thrombosis. Thrombi involved the thoracic aorta, abdominal aorta, bilateral internal iliac arteries, and left subclavian artery. Furthermore, comprehensive literature reviews show that acute pancreatitis induces arterial clots in both necrotizing and interstitial variants. Specifically, out of twelve analyzed cases, five developed within interstitial edematous pancreatitis, whereas seven involved necrotizing pancreatitis. Symptoms often mimic ordinary disease exacerbations, including persistent epigastric pain, unexplained hemodynamic instability, or severe back discomfort. Moreover, arterial thrombosis displays a biphasic temporal pattern. Clinicians diagnosed seven cases within the first hospital week, whereas five emerged several weeks later, reaching up to sixty days post-onset. Therefore, clinicians must maintain a high index of suspicion whenever patients exhibit prolonged abdominal distress or sudden peripheral circulatory failure.

Pathophysiology of Large-Vessel Occlusion in Pancreatitis

The pathogenesis of arterial thrombosis during acute pancreatitis involves multiple converging systemic and local mechanisms. First, severe retroperitoneal inflammation drives the local extravasation of pancreatic proteolytic enzymes, particularly elastase and trypsin. These active digestive enzymes erode peripancreatic tissue and damage the adjacent adventitia of major vascular structures. As a result, direct endothelial injury triggers localized platelet aggregation and initiates the extrinsic coagulation pathway. Second, acute pancreatitis provokes an intense systemic inflammatory response syndrome characterized by massive cytokine release. High circulating levels of interleukin-1, interleukin-6, and tumor necrosis factor-alpha disturb the physiological hemostatic balance. Consequently, these inflammatory mediators upregulate tissue factor expression, deplete natural anticoagulants like protein C and antithrombin, and impair fibrinolysis. In addition, third-space fluid sequestration and persistent vomiting produce profound hemoconcentration, which promotes blood hyperviscosity and stasis. Furthermore, expanding inflammatory collections, such as pseudocysts or walled-off necrosis, exert extrinsic mechanical compression on neighboring arterial trunks. This focal vascular distortion alters normal laminar blood flow, predisposing high-velocity arteries to mural thrombus formation. Thus, this unique combination of chemical endothelial injury, microvascular hypercoagulability, and extrinsic compression culminates in widespread arterial occlusion.

Diagnostic Challenges and the Value of Follow-Up Imaging

Diagnosing arterial complications in pancreatitis remains notoriously difficult because symptoms frequently overlap with baseline disease manifestations. Splanchnic venous thrombosis usually generates recognizable portal hypertension or bowel congestion, but arterial thrombi produce variable ischemic patterns. For instance, partial aortic occlusion may present silently without immediate limb ischemia or visceral gangrene. Therefore, physicians often overlook developing arterial thrombi until devastating end-organ infarction occurs. Contrast-enhanced computed tomography serves as the gold standard modality for evaluating acute peripancreatic collections and vascular integrity. However, initial imaging protocols often prioritize venous phase acquisition to detect portal and splenic vein thrombosis. Consequently, non-occlusive or floating arterial thrombi within the thoracic aorta or proximal branch vessels can escape detection. Clinicians must request biphasic or multiphase computed tomography angiography when clinical recovery stalls. In addition, unexplained lactic acidosis, refractory abdominal pain, or peripheral pulse deficits should immediately prompt urgent vascular reassessment. Repeating cross-sectional vascular imaging during late-stage disease remains critical because arterial thrombi can emerge months after index admission. Ultimately, meticulous radiologic evaluation prevents delayed detection of extensive vascular compromise.

Therapeutic Anticoagulation and Interventional Strategies

Managing arterial thrombosis in acute pancreatitis requires a delicate balance between ischemic prevention and fatal retroperitoneal bleeding. Once imaging confirms macrovascular thrombosis without active hemorrhage, physicians must initiate systemic anticoagulation promptly. Unfractionated heparin or low-molecular-weight heparin serves as the primary initial agent due to rapid reversibility. In the reported index case, systemic anticoagulation achieved complete radiologic clot resolution without secondary complications. Nevertheless, clinicians must carefully inspect baseline imaging for pseudoaneurysms, because enzyme erosion can induce catastrophic rupture during therapeutic heparinization. When patients develop acute limb-threatening ischemia or severe mesenteric hypoperfusion, medical anticoagulation alone proves insufficient. In such emergent scenarios, endovascular interventions, including catheter-directed thrombolysis or percutaneous mechanical thrombectomy, provide rapid luminal restoration. Alternatively, open vascular embolectomy remains a valuable rescue option when endovascular approaches are unavailable. Furthermore, after acute stabilization, clinicians transition patients to oral direct anticoagulants or vitamin K antagonists. Close clinical monitoring during therapy ensures that clinicians detect any emerging intracystic bleeding early. Thus, multidisciplinary coordination among gastroenterologists, vascular surgeons, and interventional radiologists optimizes patient survival and functional vessel recanalization.

Insights from Systematic Case Analysis and Clinical Guidelines

A comprehensive review of published literature provides crucial clinical insights into this rare vascular phenomenon. Among twelve recorded cases of arterial thrombosis complicating acute pancreatitis, vessel involvement was widespread and heterogeneous. Major visceral arteries and the aorta represented the primary sites of thrombus formation. Surprisingly, five patients developed severe arterial clots despite experiencing only interstitial edematous pancreatitis rather than severe necrotizing disease. This observation challenges the long-standing belief that macrovascular thrombosis occurs exclusively in extensive tissue necrosis. Additionally, mortality in acute pancreatitis increases dramatically once major arterial occlusion precipitates bowel or renal infarction. International pancreatology guidelines clearly emphasize thromboprophylaxis for venous thromboembolism, but specific recommendations for arterial thrombosis remain limited. Clinicians must therefore individualize treatment algorithms based on clot location, ischemic jeopardy, and hemorrhage risk. Moreover, documenting these rare presentations expands global clinical registries, improving institutional awareness worldwide. In summary, vigilant surveillance, prompt imaging acquisition, and aggressive yet tailored medical therapy ensure optimal recovery for affected patients.

Frequently Asked Questions

How does arterial thrombosis differ from venous thrombosis in acute pancreatitis?

Venous thrombosis occurs in up to twenty-five percent of severe pancreatitis cases, most commonly affecting the splenic, portal, or superior mesenteric veins. Conversely, arterial thrombosis represents an exceptionally rare event involving the aorta or visceral branches. While venous occlusion typically induces portal hypertension, splenomegaly, and variceal bleeding, arterial thrombosis precipitates rapid ischemic necrosis of downstream organs, including the bowel, spleen, and kidneys, demanding urgent vascular intervention.

Can arterial thrombosis develop in mild or interstitial edematous pancreatitis?

Yes, arterial thrombosis can occur in interstitial edematous pancreatitis as well as necrotizing disease. Literature reviews indicate that nearly forty percent of reported arterial thrombotic cases occurred in patients with interstitial pancreatitis. Systemic hypercoagulability, severe dehydration, and local peripancreatic fluid pressure can provoke extensive arterial clotting even in the absence of pancreatic parenchymal necrosis. Clinicians must therefore avoid assuming arterial clots only complicate necrotizing pancreatitis.

What is the recommended treatment for pancreatitis-induced arterial thrombosis?

Treatment primarily relies on therapeutic systemic anticoagulation with unfractionated or low-molecular-weight heparin, provided contraindications like active bleeding or pseudoaneurysm are absent. If severe organ or limb ischemia threatens survival, clinicians perform urgent endovascular thrombectomy, catheter-directed thrombolysis, or surgical embolectomy. Following acute stabilization, patients continue oral anticoagulants until imaging demonstrates complete vascular recanalization. Close multidisciplinary monitoring remains mandatory to prevent severe hemorrhagic complications during recovery.

Disclaimer: This content is for informational and educational purposes only. It is not intended to provide medical advice or to be used as a substitute for the independent judgement of a healthcare professional. Refer to the latest local and national guidelines for clinical practice.

References

1. Cho MS et al. Extensive Arterial Thrombosis Complicating Acute Pancreatitis: A Case Report and Literature Review. Korean J Gastroenterol. 2026 Oct 25. doi: 10.4166/kjg.2026.035. PMID: 42928010.
2. Nadkarni NA, et al. A case of widespread aortic thrombosis secondary to acute severe pancreatitis. Ann R Coll Surg Engl. 2013;95(6):e101-e103.
3. Sanekommu H, et al. Chronic Pancreatitis-Induced Thrombosis of Celiac and Superior Mesenteric Artery. J Med Cases. 2023;14(10):345-350.